Jonathan W. Friedberg
Editor-in-Chief at Journal of Global Oncology
Lymphoma expert. Director of @WilmotCancer Rochester NY. Editor-in-Chief, Journal of Clinical Oncology @asco_pubs. Tweets and opinions are my own.
Articles
-
Dec 15, 2023 |
ascopubs.org | Eileen M. O'Reilly |Andrew H. Ko |Jonathan W. Friedberg
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/authors/author-center.
-
Dec 15, 2023 |
brnw.ch | Eileen M. O'Reilly |Andrew H. Ko |Jonathan W. Friedberg
THE TAKEAWAYThe trial by Burris et al1 is a landmark study not only in the realm of pancreatic cancer but also in the larger field of clinical research.
-
Nov 20, 2023 |
brnw.ch | Kara Kelly |Jonathan W. Friedberg
SUPPORTSupported in part by National Cancer Institute (R01CA262265). Conception and design: All authorsCollection and assembly of data: All authorsData analysis and interpretation: All authorsManuscript writing: All authorsFinal approval of manuscript: All authorsAccountable for all aspects of the work: All authorsClassic Hodgkin Lymphoma in Adolescents and Young AdultsThe following represents disclosure information provided by authors of this manuscript.
-
Aug 31, 2023 |
targetedonc.com | Rahul Gosain |Rohit Gosain |Jonathan W. Friedberg
DLBCL: Real-World Use of Frontline Polatuzumab Vedotin Following the POLARIX TrialFollowing their discussion on the phase 3 POLARIX trial in DLBCL, Jonathan Friedberg, MD, MMSc, and the Oncology Brothers consider how frontline polatuzumab vedotin will be used in the real-world setting.
-
Aug 31, 2023 |
targetedonc.com | Rohit Gosain |Rahul Gosain |Jonathan W. Friedberg
2 Clarke Drive Cranbury, NJ 08512
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 5K
- Tweets
- 2K
- DMs Open
- No
Thoughtful editorial by Drs. Mohile and Ramsdale @WilmotCancer illustrating how data science, machine learning, and many-model thinking can augment clinical research amid a shifting data paradigm. @JCO_ASCO https://t.co/nuKyzqSeBk
RT @MikkaelSekeres: So thrilled to be joined by @MissMeganEl to discuss her amazing essay “Tamales” in our latest @JCO_ASCO #CancerStories…
RT @WilmotCancer: Wilmot Warrior Weekend registration is officially open! We were excited to talk about during our launch party earlier thi…
